What

A news briefing will be held on the research and clinical trials that brought about the development of Viagra, the world's first oral therapy for male erectile dysfunction (MED). Over 30 million men suffer from MED in the U.S. alone. Perspectives on the history and future of Viagra research will be presented by a key member of the Pfizer Central Research team, at the national meeting of the American Chemical Society, the world's largest scientific society, in Boston, Mass., August 24-27. It is one of 6,700 papers to be presented during the four-day meeting.

Who

Dr. Nicholas K. Terrett, Discovery Chemistry
Pfizer Central Research, Sandwich, Kent

When

Monday, August 24, 12:45 p.m.

Where

Sheraton Boston Hotel, Beacon A

Note

Information from the speaker is for release immediately following the briefing.

For Further Information, Contact:

Jodi Greenblatt, (202) 872-4381
August 24-27: Boston Press Room
(617) 351-6808 (phone); (617) 351-6820 (fax)

A nonprofit organization with a membership of more than 155,000 chemists and chemical engineers as its members, the American Chemical Society publishes scientific journals and databases, convenes major research conferences, and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.